Skip to main content
Premium Trial:

Request an Annual Quote

Duke Microarray Facility Buys a BioMicro MAUI Hybridization System

NEW YORK (GenomeWeb News) — Duke University's microarray facility has purchased a BioMicro hybridization system, the Salt Lake City-based company said today.
 
BioMicro, a microarray and microfluidics company, said Duke will use its MAUI hybridization system at the Microarray Facility and Institute for Genome Sciences and Policy.
 
Duke said it now has three MAUI systems at the facility.
 
Financial terms of the agreement were not released.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.